Print Friendly and PDF

‘Gain of Function’

“I've now read quotes from Dr. Fauci years ago about his funding of 'gain of function' research. And apparently this was performed thru an intermediary (Peter Daszak) who helped set that up in Wuhan in 2017. As I recall more recently, he was in the so-called investigation group authorized to go to China to 'investigate', while 'real' investigative epidemiologists were fully denied access to China. As 79 Dr. Fauci doesn't need the grief; but he denied it all; and Weekend Australian will expose all of this ... well now,” notes Gene Inger, The Inger Letter.

“The idea is we could have learned about 'gain of function' without any of the risks that they know existed by doing the lab/bat work the way it was handled. Huge scandal. Can that affect the market? Well in 2017 Fauci did not brief President Trump or Sec'y. Pompao; and didn't step forward in January 2020 when he inherently 'had to know' what was funded and where it took place (a picture of Daszak and the bat lady is featured in Australia's coverage). By the way 'translate' gain of function; and I get: CCP/PLA bioweapon research.”

Editor’s Note: The Inger Letter, has evolved over the decades into a daily emailed stock market analysis by Gene Inger, financial television pioneer, money manager, and periodic Top Timer in various market indexes.

The Daily Briefing, focuses on S&P technical market prospect and is distributed nightly and typically includes one or two videos as well as charts and analysis. $159/Quarterly.

MarketCast is emailed several times during the market day to investors and traders more attuned to intraday equity index swings. In addition to S&P trading guidelines, intraday action of the Dow, Dollar, Euro, treasuries, Oil, Gold, and other indexes and a few prominent stocks are analyzed. $390/Quarterly.

For more information and subscription information on the services that The Inger Letter offers visit www.ingerletter.com.

The Bull & Bear Financial Report

Copyright 2021 - 23 || All Rights Reserved
Reproduction in whole or part is strictly prohibited
without prior written permission.


NOTE: The Bull & Bear Financial Report does not itself endorse or guarantee
the accuracy or reliability of information, statements or opinions
expressed by any individuals or organizations posted on this site


The Bull & Bear Financial Report is published by
BULL & BEAR MEDIA GROUP, INC.
Info@TheBullandBear.com

Website Designed & Maintained by Gemini Communications

PLEASE READ DISCLAIMER